Naltrexone administration affects ad libitum smoking behavior

Psychopharmacology

Volumn 140, Issue 2, 1998, Pages 185-190

  Wewers, Mary Ellen ^a   Dhatt, Ravinder ^a   Tejwani, Gopi A ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Endogenous opioid peptides; Mood state; Naltrexone; Nicotine; Reinforcement; Smoking; Withdrawal symptom

Indexed keywords

NALTREXONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REINFORCEMENT; SATISFACTION; SMOKING; WITHDRAWAL SYNDROME;

ADULT; AFFECT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; NICOTINE; REINFORCEMENT (PSYCHOLOGY); SMOKING; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0031762075     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050756     Document Type: Article

References (19)

1. Ahijevych KL, Wewers ME (1994) Patterns of cigarette consumption and cotinine levels among African American women smokers. Am J Resp Crit Care Med 150 : 1229 1233
2. Davenport KE, Houdi AA, Van Loon, GR (1990) Nicotine protects against μ receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain. Neurosci Lett 113 : 40 46
3. Fiore MC, Bailey WC, Cohen SJ et al. (1996). Smoking cessation. Clinical practice guideline no. 18. Rockville, mag. US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 96 0692
4. Gorelick DA, Rose J, Jarvik ME (1989) Effects of naloxone on cigarette smoking. J Subst Abuse 1 : 153 159
5. Hariharan M, Van Noord T (1991). Liquid-chromatographic determination of nicotine and cotinine in urine from passive smokers: comparison with gas chromatography with a nitrogen-specific detector. Clin Chem 37 : 1276 1280
6. Hatsukami DK, Mitchell JE, Morley JE, Morgan SF. Levine AS (1986) Effect of maltrexone on mood and cognitive functioning among overweight men. Biol Psychiatry 21 : 293-300
7. Hurt RD, Sachs DPL, Glover ED et al (1997). A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337 : 1195-1202
8. Hutchison KE, Monti PM, Rohsenow DJ et al (1988) Effects of naltrexone and nicotine replacement on smoking cue reactivity. Proceedings from the 4th Annual Meeting of the Society for Research on Nicotine and Tobacco. March 27 29, 1998 New Orleans
9. Jarvis MJ, Russell MAH, Saloojee Y (1980) Expired air carbon monoxide: a simple test of tobacco smoke intake. BMJ 281 : 484-485
10. Karras A, Kane JM (1980) Naloxone reduces cigarette smoking. Life Sci 27 : 1541 1545
11. Keppel G (1982) Design and analysis: a researcher's handbook. Prentice-Hall, Engelwood Cliffs. N.J.
12. McNair DM, Lorr M, Droppleman LF (1971) ETIS manual for the profile of mood states. Education & Industrial Testing Science, San Diego
13. Nemeth-Coslett R, Griffiths RR (1986) Naloxone does not affect cigarette smoking. Psychopharmacology 89 : 261-264
14. Palmer RF, Berens A (1983) Double-blind study of the effect of naloxone on the pleasure of smoking. Fed Proc 42 : 654
15. Shiffman S, Jarvik ME (1976) Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology 50 : 35-39
16. Sutherland G, Stapleton JA, Russel MAH, Feyerabend C (1995) Naltrexone, smoking behavior and cigarette withdrawal. Psychopharmacology 120 : 418 425
17. Tejwani G (1981) Pharmacologic and other effects of opiate agonists and antagonists. Recent Adv Clin Ther 1 : 193-216
18. Tripathi HL, Martin BR, Aceto MD (1982) Nicotine-induced antinociception in rats and mice: correlation with nicotine brain levels. J Pharmacol Exp Ther 221 : 91 96
19. West RJ, Hajek P. McNeill A (1991) Effect of buspirone on cigaratte withdrawal symptoms and short-term abstinence rates in a smokers clinic. Psychopharmacology 104 : 91 96